Novel δ1-receptor agonist KNT-127 increases the release of dopamine and l-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex

Neuropharmacology

Volumn 62, Issue 5-6, 2012, Pages 2057-2067

  Tanahashi, Shunsuke ^a   Ueda, Yuto ^b   Nakajima, Akira ^b   Yamamura, Satoshi ^a   Nagase, Hiroshi ^c   Okada, Motohiro ^a  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Dopamine; GABA; KNT 127; l glutamate; Microdialysis

Indexed keywords

4 AMINOBUTYRIC ACID; 7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR 1; DELTA OPIATE RECEPTOR AGONIST; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; KNT 127; MUSCIMOL; NALTRIBEN; NEW DRUG; SULPIRIDE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TARGETING; GLUTAMATE RELEASE; GLUTAMATERGIC TRANSMISSION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICRODIALYSIS; MORPHINANS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA;

EID: 84857056358     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.01.005     Document Type: Article

References (54)

1. F. Billet, N. Dourmap, and J. Costentin Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors Eur. J. Neurosci. 20 2004 2629 2638 (Pubitemid 39573778)
2. E.J. Bilsky, S.N. Calderon, T. Wang, R.N. Bernstein, P. Davis, V.J. Hruby, R.W. McNutt, R.B. Rothman, K.C. Rice, and F. Porreca SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist J. Pharmacol. Exp. Ther. 273 1995 359 366
3. K.E. Bosse, E.M. Jutkiewicz, M.E. Gnegy, and J.R. Traynor The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum Neuropharmacology 55 2008 755 762
4. J.P. Britt, and D.S. McGehee Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens J. Neurosci. 28 2008 1672 1681 (Pubitemid 351287040)
5. D.C. Broom, E.M. Jutkiewicz, J.E. Folk, J.R. Traynor, K.C. Rice, and J.H. Woods Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats Neuropsychopharmacology 26 2002 744 755 (Pubitemid 34455027)
6. S.N. Calderon, K.C. Rice, R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, H. Kayakiri, H. Xu, K. Becketts, L.E. Smith, E.J. Bilsky, P. Davis, and R. Horvath Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]- N, N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands J. Med. Chem. 40 1997 695 704 (Pubitemid 27102575)
7. A. Carlsson, N. Waters, S. Holm-Waters, J. Tedroff, M. Nilsson, and M.L. Carlsson Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annu. Rev. Pharmacol. Toxicol. 41 2001 237 260 (Pubitemid 32385889)
8. K.J. Chang, G.C. Rigdon, J.L. Howard, and R.W. McNutt A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86 J. Pharmacol. Exp. Ther. 267 1993 852 857 (Pubitemid 23352547)
9. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245 (Pubitemid 34465544)
10. N. Dourmap, A. Michael-Titus, and J. Costentin Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study Brain Res. 524 1990 153 155 (Pubitemid 20254709)
11. K. Fusa, I. Takahashi, S. Watanabe, Y. Aono, H. Ikeda, T. Saigusa, H. Nagase, T. Suzuki, N. Koshikawa, and A.R. Cools The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals Neuroscience 130 2005 745 755 (Pubitemid 39601446)
12. W. Hauber Involvement of basal ganglia transmitter systems in movement initiation Prog. Neurobiol. 56 1998 507 540 (Pubitemid 28407570)
13. C.J. Hille, S.H. Fox, Y.P. Maneuf, A.R. Crossman, and J.M. Brotchie Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease Exp. Neurol. 172 2001 189 198 (Pubitemid 33143821)
14. T.J. Hudzik, C. Maciag, M.A. Smith, R. Caccese, M.R. Pietras, K.H. Bui, M. Coupal, L. Adam, K. Payza, A. Griffin, G. Smagin, D. Song, M. Swedberg, and B. Brown Preclinical pharmacology of AZD2327 - a highly selective agonist of the {delta} opioid receptor J. Pharmacol. Exp. Ther. 338 2011 195 204
15. Z.G. Jiang, and R.A. North Pre- and postsynaptic inhibition by opioids in rat striatum J. Neurosci. 12 1992 356 361
16. E.M. Jutkiewicz, E.B. Eller, J.E. Folk, K.C. Rice, J.R. Traynor, and J.H. Woods Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats J. Pharmacol. Exp. Ther. 309 2004 173 181 (Pubitemid 38393128)
17. J. Kamei, A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, H. Nagase, and Y. Kasuya Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice Eur. J. Pharmacol. 276 1995 131 135
18. M. Kamibayashi, S. Oowada, H. Kameda, T. Okada, O. Inanami, S. Ohta, T. Ozawa, K. Makino, and Y. Kotake Synthesis and characterization of a practically better DEPMPO-type spin trap, 5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5- methyl-1-pyrroline N-oxide (CYPMPO) Free Radic. Res. 40 2006 1166 1172 (Pubitemid 44490157)
19. S. Kohri, H. Fujii, S. Oowada, N. Endoh, Y. Sueishi, M. Kusakabe, M. Shimmei, and Y. Kotake An oxygen radical absorbance capacity-like assay that directly quantifies the antioxidant's scavenging capacity against AAPH-derived free radicals Anal. Biochem. 386 2009 167 171
20. J. Le Merrer, J.A. Becker, K. Befort, and B.L. Kieffer Reward processing by the opioid system in the brain Physiol. Rev. 89 2009 1379 1412
21. C. Le Moine, B. Kieffer, C. Gaveriaux-Ruff, K. Befort, and B. Bloch Delta-opioid receptor gene expression in the mouse forebrain: localization in cholinergic neurons of the striatum Neuroscience 62 1994 635 640 (Pubitemid 24325641)
22. R. Longoni, C. Cadoni, A. Mulas, G. Di Chiara, and L. Spina Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats Behav. Pharmacol. 9 1998 9 14 (Pubitemid 28098662)
23. I. Madar, J.R. Lever, C.M. Kinter, U. Scheffel, H.T. Ravert, J.L. Musachio, W.B. Mathews, R.F. Dannals, and J.J. Frost Imaging of delta opioid receptors in human brain by N1′-([11C]methyl)naltrindole and PET Synapse 24 1996 19 28 (Pubitemid 26293164)
24. Y.P. Maneuf, I.J. Mitchell, A.R. Crossman, and J.M. Brotchie On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus Exp. Neurol. 125 1994 65 71 (Pubitemid 24067604)
25. A. Mansour, C.A. Fox, S. Burke, F. Meng, R.C. Thompson, H. Akil, and S.J. Watson Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study J. Comp. Neurol. 350 1994 412 438 (Pubitemid 24356007)
26. M. Murata Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease Curr. Pharm. Des 10 2004 687 693 (Pubitemid 38292396)
27. M. Murata, K. Hasegawa, and I. Kanazawa Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study Neurology 68 2007 45 50 (Pubitemid 46058551)
28. H. Nagase, Y. Yajima, H. Fujii, K. Kawamura, M. Narita, J. Kamei, and T. Suzuki The pharmacological profile of delta opioid receptor ligands, (+) and (-) TAN-67 on pain modulation Life Sci. 68 2001 2227 2231 (Pubitemid 32452377)
29. H. Nagase, T. Nemoto, A. Matsubara, M. Saito, N. Yamamoto, Y. Osa, S. Hirayama, M. Nakajima, K. Nakao, H. Mochizuki, and H. Fujii Design and synthesis of KNT-127, a delta-opioid receptor agonist effective by systemic administration Bioorg. Med. Chem. Lett. 20 2010 6302 6305
30. S.S. Negus, E.R. Butelman, K.J. Chang, B. DeCosta, G. Winger, and J.H. Woods Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys J. Pharmacol. Exp. Ther. 270 1994 1025 1034 (Pubitemid 24315216)
31. K. Ohoyama, S. Yamamura, T. Hamaguchi, M. Nakagawa, E. Motomura, T. Shiroyama, H. Tanii, and M. Okada Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex Eur. J. Pharmacol. 653 2010 47 57
32. M. Okada, S. Kaneko, T. Hirano, M. Ishida, T. Kondo, K. Otani, and Y. Fukushima Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release Epilepsy Res. 13 1992 113 119
33. M. Okada, S. Kaneko, T. Hirano, K. Mizuno, T. Kondo, K. Otani, and Y. Fukushima Effects of zonisamide on dopaminergic system Epilepsy Res. 22 1995 193 205
34. M. Okada, D.J. Nutt, T. Murakami, G. Zhu, A. Kamata, Y. Kawata, and S. Kaneko Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release J. Neurosci. 21 2001 628 640 (Pubitemid 32107452)
35. M. Okada, G. Zhu, S. Yoshida, S. Hirose, and S. Kaneko Protein kinase associated with gating and closing transmission mechanisms in temporoammonic pathway Neuropharmacology 47 2004 485 504 (Pubitemid 39221773)
36. M.C. Olianas, S. Dedoni, R. Ambu, and P. Onali Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex Eur. J. Pharmacol. 607 2009 96 101
37. P. Onali, S. Dedoni, and M.C. Olianas Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes J. Pharmacol. Exp. Ther. 332 2010 255 265
38. G. Paxinos, and C. Watson The Rat Brain: In Stereotaxic Coordinates 1998 Academic Press San Diego
39. M.L. Perreault, A. Hasbi, M. Alijaniaram, T. Fan, G. Varghese, P.J. Fletcher, P. Seeman, B.F. O'Dowd, and S.R. George The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia J. Biol. Chem. 285 2011 36625 36634
40. C. Remblier, R. Pontcharraud, C. Tallineau, A. Piriou, and F. Huguet Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxidative mechanisms Brain Res. 837 1999 22 28 (Pubitemid 29369213)
41. A. Saitoh, A. Sugiyama, T. Nemoto, H. Fujii, K. Wada, J.I. Oka, H. Nagase, and M. Yamada The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions Behav. Brain Res. 2011
42. M. Seino Review of zonisamide development in Japan Seizure 13 Suppl. 1 2004 S2 S4
43. G.N. Smagin, D. Song, A. Medd, A.J. Cross, T. Hudzik, and L. Mrzljak Neurochemical validation of centrally active delta-opioid receptor agonists as novel treatment of anxiety disorders Eur. Neuropsychopharmacol. 18 2008 496
44. L. Spina, R. Longoni, A. Mulas, K.J. Chang, and G. Di Chiara Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats Behav. Pharmacol. 9 1998 1 8 (Pubitemid 28098661)
45. A.L. Svingos, C.L. Clarke, and V.M. Pickel Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin J. Neurosci. 18 1998 1923 1933 (Pubitemid 28103100)
46. S. Tanahashi, S. Yamamura, M. Nakagawa, E. Motomura, and M. Okada Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes Br. J. Pharmacol. 2011
47. S. Tanahashi, S. Yamamura, M. Nakagawa, E. Motomura, and M. Okada Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission Neuropharmacology 62 2012 765 774
48. L.F. Tseng, M. Narita, H. Mizoguchi, K. Kawai, A. Mizusuna, J. Kamei, T. Suzuki, and H. Nagase Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-) TAN-67, in the mouse spinal cord J. Pharmacol. Exp. Ther. 280 1997 600 605 (Pubitemid 27171318)
49. H. Wang, and V.M. Pickel Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors J. Neurosci. 21 2001 3242 3250 (Pubitemid 32323506)
50. S. Yamamura, K. Ohoyama, T. Hamaguchi, K. Kashimoto, M. Nakagawa, S. Kanehara, D. Suzuki, T. Matsumoto, E. Motomura, T. Shiroyama, and M. Okada Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex Psychopharmacology (Berl) 206 2009 243 258
51. S. Yamamura, K. Ohoyama, T. Hamaguchi, M. Nakagawa, D. Suzuki, T. Matsumoto, E. Motomura, H. Tanii, T. Shiroyama, and M. Okada Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex Br. J. Pharmacol. 157 2009 656 665
52. S. Yamamura, K. Ohoyama, H. Nagase, and M. Okada Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway Neuropharmacology 57 2009 322 331
53. S. Yamamura, H. Saito, N. Suzuki, S. Kashimoto, T. Hamaguchi, K. Ohoyama, D. Suzuki, S. Kanehara, M. Nakagawa, T. Shiroyama, and M. Okada Effects of zonisamide on neurotransmitter release associated with inositol triphosphate receptors Neurosci. Lett. 454 2009 91 96
54. Y. Zhu, M.A. King, A.G. Schuller, J.F. Nitsche, M. Reidl, R.P. Elde, E. Unterwald, G.W. Pasternak, and J.E. Pintar Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice Neuron 24 1999 243 252 (Pubitemid 29466162)